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Pseudomonas aeruginosa is an opportunistic pathogen responsible for many diseases
such as chronic lung colonization in cystic fibrosis patients and acute infections in
hospitals. The capacity of P. aeruginosa to be pathogenic toward several hosts is
notably due to different secretion systems. Amongst them, P. aeruginosa encodes three
Type Six Secretion Systems (T6SS), named H1- to H3-T6SS, that act against either
prokaryotes and/or eukaryotic cells. They are independent from each other and inject
diverse toxins that interact with different components in the host cell. Here we summarize
the roles of these T6SSs in the PAO1 strain, as well as the toxins injected and their
targets. While H1-T6SS is only involved in antiprokaryotic activity through at least seven
different toxins, H2-T6SS and H3-T6SS are also able to target prokaryotic as well as
eukaryotic cells. Moreover, recent studies proposed that H2- and H3-T6SS have a role
in epithelial cells invasion by injecting at least three different toxins. The diversity of
T6SS effectors is astounding and other effectors still remain to be discovered. In this
review, we present a table with other putative P. aeruginosa strain PAO1 T6SS-dependent
effectors. Altogether, the T6SSs of P. aeruginosa are important systems that help fight
other bacteria for their ecological niche, and are important in the pathogenicity process.
Keywords: Pseudomonas aeruginosa, Type Six Secretion System, invasion mechanism, epithelial cells, gamma-
tubulin complex, microtubules, PI3K Akt pathway, antibacterial activity
The Type Six Secretion system (T6SS) was discovered ten years ago in the laboratory of Pr. J.
Mekalanos (Mougous et al., 2006; Pukatzki et al., 2006). It functions as a contractile molecular
syringe consisting of a sheath and a puncturing device made of an Hcp tube terminated by a spike
of VgrG and PAAR proteins. Contraction of the TssB/C sheath propels the puncturing device out of
the cell into a target cell and leads to the injection of effector proteins (AlcoforadoDiniz et al., 2015).
The first studies focused on the phenotypes associated with T6SS mutations in different pathogens
in the context of eukaryotic host infection. However in 2010, Dr. J. Mougous laboratory showed an
unsuspected antibacterial activity mediated by the H1-T6SS from Pseudomonas aeruginosa, making
T6SSs transkingdommachineries (Hood et al., 2010). Since this discovery, T6SSs have mainly been
studied for their capacity to target prokaryotes and this would seem to be their primary function.
But interestingly, several T6SSs are also known to target both prokaryotes and eukaryotes such as
the T6SS of Vibrio cholera (Pukatzki et al., 2006; MacIntyre et al., 2010).
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P. aeruginosa is one of the most virulent opportunistic
human pathogens and is responsible for many diseases such as
broncho-alveolar colonization in cystic fibrosis patients or acute
infections of lungs and burned skin that can lead to septicemia.
Its genome encodes many virulence factors including several
secretion systems that help P. aeruginosa control its environment
and the activity of host cells (Bleves et al., 2010). Among theses,
P. aeruginosa harbors three independent Type Six Secretion
Systems (T6SS). This review will aim to describe the roles,
effectors, and targets of these three T6SSs.
P. AERUGINOSA USES T6SSS AS
ANTIPROKARYOTIC WEAPONS
T6SSs are present in more than 200 Gram-negative bacteria
including P. aeruginosa, whose genome encodes three different
T6SS loci named H1-, H2-, and H3-T6SS (Table 1). Historically,
H1-T6SS is the first T6SS machinery that was shown to display
an antibacterial activity (Hood et al., 2010). H1-T6SS serves as
a counter-attack weapon to outcompete other T6SS+ bacteria
that coexist in a same ecological niche, and confers a growth
advantage upon P. aeruginosa (Basler et al., 2013). More
specifically, P. aeruginosa targets other bacteria through H1-
T6SS dependent injection of effector Tse2 and also produces an
anti-toxin Tsi2, protecting itself against the intrinsic effect of
the toxin and from attack by sister-cells (Hood et al., 2010). It
was recently shown that Tse2 induces quiescence in bacterial
target cells, and that Tsi2 directly interacts with Tse2 in the
cytoplasm to inactivate its lethal activity (Li et al., 2012). Recently,
Tse2 toxicity was shown to be NAD-dependent and may involve
an ADP-ribosyltransferase activity (Robb et al., 2016). Besides
Tse2, which acts in the cytoplasm of prey cells, Tse1 and
Tse3 are injected into the periplasm of target bacterial cells
through H1-T6SS (Russell et al., 2011). Tse1 and Tse3 hydrolyse
peptidoglycan, providing a fitness advantage for P. aeruginosa
in competition with other bacteria. To protect from killing
by sister-cells, P. aeruginosa uses the periplasmic immunity
proteins Tsi1 and Tsi3 which counteract Tse1 and Tse3 toxicity
(Russell et al., 2011). Later, X-ray studies revealed that Tse1
cleaves the γ-D-glutamyl-l-meso-diaminopimelic acid amide
bond of crosslinked peptidoglycan (Benz et al., 2012; Chou et al.,
2012). Moreover, the crystal structure of Tse1 in interaction
with Tsi1 demonstrates that the immunity protein occludes the
active site of Tse1 abolishing its enzyme activity (Benz et al.,
2012). Tse3 functions as a muramidase, cleaving the β-1,4-
linkage between N-acetylmuramic acid and N-acetylglucosamine
in peptidoglycan (Lu et al., 2013). These three effectors were
discovered in 2010 thanks to their coregulation with the H1-T6SS
machinery (Table 1), and other H1-T6SS toxins were described
later. Tse4 was identified as a H1-T6SS effector using quantitative
cellular proteomics in interaction with Hcp (Whitney et al.,
2014). Tse5, Tse6, and Tse7 were identified by their genetic
association with VgrGs and the H1-T6SS (Hachani et al., 2014;
Whitney et al., 2014). Those four effectors display antibacterial
activity and are associated with cognate immunities (Table 1).
Recently Tse6 was shown to degrade the essential dinucleotides
NAD(+) and NADP(+) leading to bacteriostasis in the target
bacterium (Whitney et al., 2015). Intriguingly Tse6 delivery into
the host cytoplasm requires translation elongation factor Tu (EF-
Tu). The interaction of a toxin with a house keeping protein
may suggest that it can target phylogenetically diverse bacteria
(Whitney et al., 2015). EF-Tu may facilitate Tse6 translocation
into recipient cells or by driving the H1-T6SS needle at the
cell surface of the preys either by favoring the passage of
the toxin once delivered into the periplasm to the cytoplasm.
Indeed EF-Tu is known as a moonlighting protein or anchorless
multifunctional protein that is capable, when localized to the cell
surface, of interfering with bacterial adherence (for a review see
Henderson and Martin, 2011). Importantly work done on H1-
T6SS toxins has revealed different conserved mechanisms for
targeting T6SS effectors to the T6SSmachinery (Table 1): (i) Hcp-
dependent recruitment in the case of Tse1-4, (ii) direct VgrG-
targeting for Tse5, (iii) VgrG-targeting for Tse7 through a PAAR
motif and for Tse6 through an adaptator/chaperonne protein
called EagT6. Altogether, H1-T6SS is a formidable antibacterial
weapon, injecting many different effectors to compete bacterial
cells, and allowing P. aeruginosa to overwhelm them during
competition for the same ecological niche.
H2-T6SS and H3-T6SS also display antibacterial activity by
injecting the phospholipase D enzymes PldA and PldB that
belong to the Tle5 (type VI lipase effector) family into other
bacterial cells (Russell et al., 2013; Jiang et al., 2014). The
PldA toxin functions by degrading the major constituent of
bacterial membranes, phosphatidylethanolamine (Russell et al.,
2013). However, despite strong evidence that P. aeruginosa
T6SSs participate widely in bacterial competition, several recent
reports have focused on the ability of H2 and H3-T6SS to target
epithelial cells.
P. AERUGINOSA T6SSS ALSO TARGET
EUKARYOTIC CELLS
So far, H1-T6SS has never been shown to be directly involved
in anti-eukaryotic activity. However, Hcp1 has been found
in pulmonary secretions of cystic fibrosis patients as well as
Hcp1-specific antibodies in their sera (Mougous et al., 2006),
suggesting that the antiprokaryotic activity of H1-T6SS could
be necessary for host colonization in a complex microbial
community. Interestingly, several members of the gut microbiota
actually encode T6SSs that could lead to the contact-dependent
killing of other bacteria, including Bacteroidetes fragilis (Russell
et al., 2014). This opens a new field of research at the interface
between the pathogen, host and microbiota, giving a protective
role for the commensal microbiota through T6SS-dependent
killing of the pathogen. In support of this hypothesis, V. cholerae
needs some of its antitoxins to establish in the host gut, strongly
suggesting that it is subject to T6SS attacks from the microbiota
(Fu et al., 2013). Moreover, it was shown that about half of
the Bacteroidales genomes, the most prevalent Gram-negative
bacterial order of the human gut, encode at least one T6SS (Coyne
et al., 2016). Finally, a recent report shows that the antibacterial
activity of Bacteroidetes fragilis is active in the mice gut and that
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it kills several members of the microbiota in vitro, suggesting a
role in the gut colonization (Chatzidaki-Livanisa et al., 2016).
Altogether, the T6SS antibacterial activity clearly has a role in the
eukaryotic host as well, and should be studied into more details.
Despite being considered an extracellular pathogen, several
reports demonstrate that P. aeruginosa actively invades non-
phagocytic cells, such as the epithelial cells that line the mucosal
barrier and the endothelial cells that form the vascular lumen
(Chi et al., 1991; Engel and Eran, 2011). The entry step requires
the actin network, most probably to allow membrane protrusion
(Fleiszig et al., 1995). This is thought to help bacteria avoiding
the immune system or to invade deeper tissues during the
infection process. Although, bacteria are present in the lumen
and therefore at the apical side of the epithelium, P. aeruginosa
can only internalize through membrane that displays basolateral
characteristics (Figure 1). To circumvent this, P. aeruginosa is
able to transform apical membrane into basolateral membrane,
creating a local microenvironment that facilitates colonization
and entry into the epithelium (Kierbel et al., 2007). Interestingly,
P. aeruginosa is also able to transmigrate through an epithelial
barrier, taking advantage of cell division sites and senescent cell
extrusion (Golovkine et al., 2016). Altogether, these convergent
mechanisms for entering or crossing the epithelial barrier suggest
that this ability is essential for successful colonization of the host
by P. aeruginosa.
Themechanism by which P. aeruginosa recruits host factors to
internalize within non-phagocytic cells is still poorly understood.
Among the various factors required for this process (for a
review see Engel and Eran, 2011), we demonstrated that
the H2-T6SS machinery (Figure 1) promotes the uptake of
P. aeruginosa into pulmonary epithelial cells but, at the time,
the identity of the cognate effector(s) involved remained to
be discovered (Sana et al., 2012). Two recent reports have
enabled key new insights into the T6SS-mediated invasion
mechanism of P. aeruginosa. Host-cell invasion requires two
phospholipase D enzymes, PldA and PldB, which are injected
via the H2-T6SS or H3-T6SS machineries, respectively (Jiang
et al., 2014; Table 1). The H3-T6SS machinery is thus required
for P. aeruginosa internalization. PldA and PldB both target
the host PI3K (phosphoinositide 3-kinase)/Akt pathway, which
is hijacked during the internalization process (Kierbel et al.,
2005; Engel and Eran, 2011). After injection into epithelial
cells, the two T6SS effectors were shown to directly bind Akt,
which may lead to activation of the PI3K-Akt signaling pathway.
Indeed, Akt phosphorylation is thought to promote a profound
remodeling of the apical membrane in which protrusions
enriched in PIP3 (phosphatidylinositol-3,4,5-triphosphate) and
actin form, facilitating further entry of P. aeruginosa (Bleves
et al., 2014; Jiang et al., 2014). Interestingly, PldA and PldB
are also known to target bacterial cells, making them trans-
kingdom effectors (Bleves et al., 2014). Host-cell invasion
also requires the evolved VgrG2b effector (Sana et al., 2015).
VgrG2b is injected via the H2-T6SS into epithelial cells where
it targets the microtubule network and more interestingly the
gamma-tubulin ring complex components (γ-TuRC) of the
microtubule nucleating-center (Kollman et al., 2011; Table 1).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 June 2016 | Volume 6 | Article 61
Sana et al. P. aeruginosa T6SS Effectors
FIGURE 1 | Model of T6SS-dependent internalization of P. aeruginosa into epithelial cells. In the proposed model, VgrG2b targets γ-TuRC, which could lead
to the recruitment of PI3K at the apical membrane. Then, PldA/B both target Akt leading to actin remodeling and finally to the entry of P. aeruginosa.
Remarkably this interaction is followed by a microtubule-
dependent internalization of the pathogen since treatment of
epithelial cells with drugs that disrupt the microtubule network
decreases the number of internalized bacteria. Furthermore,
injection of VgrG2b via the H2-T6SS machinery can be bypassed
by directly producing VgrG2b in epithelial cells prior to infection.
This can even lead to the internalization of H2-T6SS or vgrG2b
mutants suggesting that VgrG2b is a central player in this
process.
How can microtubule and actin cytoskeletons be integrated
in a common invasion process? In Figure 1 we propose a
working model that is restricted to the internalization mediated
by the T6SS effector interplay. As mentioned above, the
internalization of P. aeruginosa is a multifactorial process,
and our goal here is to integrate and discuss the functions
of the three anti-eukaryotic T6SS effectors encoded by the
P. aeruginosa genome. H2-T6SS first injects VgrG2b which
targets the microtubule network and in particular γ-TuRC.
This interaction could subvert the polarization of epithelial cells
by creating novel sites of non-radial microtubule nucleation
along the apical-basal axis at the bacterium-binding site. These
new sites would be enriched in microtubule-minus ends, which
might interfere with the directional transport of microtubule-
dependent cargoes in the cell among them the basal PI3Kmarker.
Concomitantly, P. aeruginosa may also recruit Akt via the PldA
and PldB effectors injected by the H2 and H3-T6SS machineries
respectively. Indeed the apical PI3K may lead to PIP3 synthesis
and recruitment of Akt creating a basolateral environment
at the apical surface (Figure 1). This will activate the Akt
signaling, allowing actin-dependent membrane protrusion, and
ultimately the internalization of P. aeruginosa into epithelial cells
(Figure 1). One can also propose that these protrusions may
also contain microtubules. In this model, both H2 and H3-T6SS
are essential components for the internalization process of P.
aeruginosa into epithelial cells. We propose that H2-T6SS is
active before H3-T6SS because (i) transcriptional studies show
that it is expressed earlier in the growth phase (Sana et al.,
2013), (ii) ectopic synthesis of VgrG2b inside epithelial cells
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trigger internalization of T6SS mutants (Sana et al., 2015), and
(iii) PldA and PldB can compensate for each other during
infection with stationary-phase grown bacteria (Jiang et al.,
2014). However, the exact molecular mechanism by which
VgrG2b acts on the γ-TuRC and the microtubule network has
yet to be deciphered. Also, what is the nature of the effector
domain of the evolved VgrG2b? How does the interaction of Akt
with these two phospholipases D trigger its activation? Finally,
the intracellular lifestyle of P. aeruginosa has to be studied in
greater detail, particularly in light of very interesting reports
which propose that P. aeruginosa creates its own bleb-niche in
epithelial cells where it can replicate (Angus et al., 2008; Jolly
et al., 2015).
More efforts have to be made to decipher this entire
mechanism because it could lead to important biomedical
applications. Indeed, P. aeruginosa is known to induce acute
infection in patients with burned skin. Rationally, in this
scenario, the first barrier P. aeruginosa will have to cross will
be the skin, which is basically composed of epithelial cells.
We also know that H2-T6SS and H3-T6SS are important for
full virulence in worm models as well as in mouse models
(Lesic et al., 2009; Sana et al., 2013). Therefore, it begs the
question as to whether H2 or H3-T6SS are responsible for
pathogen entry through the burned skin barrier. It will therefore
be very interesting over the next years to study this invasion
mechanism more deeply using for example a three dimensional
model of burned skin (Shepherd et al., 2009). Thus, H2- and
H3-T6SS of P. aeruginosa are potentially good candidates for
new therapeutic targets. And finally, although most invasive
bacteria manipulate host actin for entry (Cossart and Sansonetti,
2004) this T6SS-mediated entry mechanism could be common in
other pathogens such as Campylobacter jejuni, and Citrobacter
freundii, Neisseria gonorrhoeae, or Burkholderia cepacia that
also appear to modulate the microtubule network to invade
epithelial cells (Donnenberg et al., 1990; Oelschlaeger et al., 1993;
Grassme et al., 1996; Yoshida and Sasakawa, 2003; Taylor et al.,
2010).
CONCLUSIONS
The T6SS machineries of P. aeruginosa must be considered as
versatile weapons that are able to target both prokaryotic and
eukaryotic cells. In the future, studies should aim at determining
the role of their antiprokaryotic activity in vivo because H1-
T6SS is clearly active in cystic fibrosis patients. One could also
ask whether this T6SS-driven antibacterial activity is a common
weapon used by pathogens in vivo to outcompete either the
commensal microbiota or other pathogens. As shown in Table 1
the repertoire of T6SS effectors in P. aeruginosa may not be
complete and at least 4 H2-T6SS putative effectors can be
proposed according to their genetic linkage with known effector
genes (Table 1). Also, the exact mechanism of T6SS-dependent
internalization within epithelial cells should be studied in more
detail and its role in colonization and pathogenicity should be
better understood.
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